Marlowe plc (AIM:MRL) acquired Gel Limited for £20.6 million on June 9, 2021. The consideration comprise an upfront cash consideration of £15.8 million and performance-related contingent consideration of £4.8 million. The acquisition will be funded from Marlowe's existing cash resources. For the year ended March 31, 2021, Healthwork generated operating profits of £2.6 million on revenues of £10.4 million and net assets at March 31, 2021 were £2.6 million. Nicholas Wells and Ben Jeynes of Cenkos Securities plc and Nick Hasell and Alex Le May of FTI Consulting acted as financial advisor for Marlowe plc.

Marlowe plc (AIM:MRL) completed the acquisition of Gel Limited for £20.6 million on June 9, 2021.